FONAR (NASDAQ:FONR - Get Free Report) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $0.29 earnings per share for the quarter, Zacks reports. FONAR had a net margin of 7.68% and a return on equity of 4.95%. The firm had revenue of $24.95 million for the quarter.
FONAR Stock Performance
FONR traded up $0.07 during midday trading on Friday, hitting $14.78. The stock had a trading volume of 6,903 shares, compared to its average volume of 14,580. FONAR has a 1 year low of $14.05 and a 1 year high of $23.41. The business has a fifty day moving average of $15.45 and a 200 day moving average of $15.94. The company has a market cap of $93.54 million, a P/E ratio of 12.85 and a beta of 1.23.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded FONAR from a "strong-buy" rating to a "buy" rating in a research report on Saturday, November 16th.
Read Our Latest Stock Analysis on FONAR
FONAR Company Profile
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Stories

Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.